Biologic drugs in treating allergic bronchopulmonary aspergillosis in patients with cystic fibrosis: a systematic review.

Sara Manti Alessandro Giallongo Giuseppe Fabio ParisiMaria PapaleEnza MulèDonatella AloisioNovella RotoloSalvatore Leonardi

Published in: European respiratory review : an official journal of the European Respiratory Society (2022)

Scientific evidence is insufficient to support firm conclusions and randomised clinical trials are urgently required to investigate the efficacy and safety of biologics for ABPA in CF patients.

Keyphrases

clinical trial
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
prognostic factors
rheumatoid arthritis